Health
Dupilumab Restores Skin Barrier in Children With Eczema
A new study shows dupilumab significantly restores skin barrier function in children with moderate-to-severe atopic dermatitis, improving both visible lesions and clinically unaffected skin.
Key Takeaways
- Dupilumab restores skin barrier function at both eczema lesions and clinically normal skin
- Drug blocks IL-4 and IL-13 inflammatory signals that impair barrier construction
- Finding suggests disease modification rather than just symptom suppression
DE
DT Editorial AI··via medicalxpress.com